TipRanks
Advertisement
Advertisement
Dice Therapeutics downgraded to Market Perform from Outperform at SVB Securities
PremiumThe FlyDice Therapeutics downgraded to Market Perform from Outperform at SVB Securities
3y ago
Dice Therapeutics downgraded to Neutral from Buy at Guggenheim
Premium
The Fly
Dice Therapeutics downgraded to Neutral from Buy at Guggenheim
3y ago
Dice Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Dice Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
3y ago
Dice Therapeutics price target raised to $48 from $38 at Wells Fargo
PremiumThe FlyDice Therapeutics price target raised to $48 from $38 at Wells Fargo
3y ago
DICE Surges after $2.4 Billion Acquisition by LLY
Premium
Market News
DICE Surges after $2.4 Billion Acquisition by LLY
3y ago
Eli Lilly to acquire Dice Therapeutics for $48 per share in cash
Premium
The Fly
Eli Lilly to acquire Dice Therapeutics for $48 per share in cash
3y ago
Cantor biopharma/biotech analysts hold analyst/industry conference call
PremiumThe FlyCantor biopharma/biotech analysts hold analyst/industry conference call
4y ago
Cantor biopharma/biotech analysts hold analyst/industry conference call
Premium
The Fly
Cantor biopharma/biotech analysts hold analyst/industry conference call
4y ago
Cantor biopharma/biotech analysts hold analyst/industry conference call
Premium
The Fly
Cantor biopharma/biotech analysts hold analyst/industry conference call
4y ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―